Scholars Central

Conference abstractPublished 21 Sep 2015

Magnetic resonance imaging of blood-brain barrier dysfunction as a biomarker for Epileptogenesis

Authors: Guy Bar Klein, Netta Elazary, Nadav Milk, Yossi Rosman, Svetlana Lublinsky, Evyatar Swissa, Arik Eizenkraft, Lyn Kamintsky, Yisrael Parmet, Yoash Chassidim, Daniela Kaufer, Alon Friedman

1Ben-Gurion University of the Negev, Israel 2Israeli Defense Forces, Israel 3Ministry of Defense, Israel 4Hebrew University, Israel 5University of California, USA 6Dalhousie University, Canada

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Acquired epilepsy is frequently followed brain insults. Interestingly, these insults are frequently associated with dysfunctional Blood-Brain Barrier (BBB). We recently showed that BBB injury lead to albumin-mediated activation of Transforming Growth Factor Ã?² (TGF-Ã?²) signaling in astrocytes, astrogliosis, local inflammatory response followed by epileptiform discharges and delayed seizures. Importantly, the FDA-approved AT1 antagonist, losartan, blocked albumin-induced TGF-Ã?² signaling and prevents epileptogenesis. Here we performed a longitudinal study in rats exposed to paraoxon to induce Status Epilepticus (SE) and epileptogenesis and executed repeated Magnetic Resonance Imaging (MRI) to quantitatively monitor BBB integrity. Continuous video Electrocorticographic (ECoG) recordings were acquired to monitor for seizures. Analysis of the ECoG signals revealed that 13 out of 22 of the rats presented âÂ?¥2 spontaneous seizures and therefore were defined as epileptic. Signal analysis in 13 defined brain regions using logistic regression and forward selection suggested that focal BBB breakdown in olfactory structures increases the likelihood of a rat to become epileptic while diffuse damage decreases this likelihood. We, thus, were able to predict epilepsy with high sensitivity and specificity (92.3% and 77.8%, respectively) with 12 out of 13 epileptic rats classified correctly and only 2 out of 9 non-epileptics falsely classified as epileptic. Our results demonstrate that increased BBB permeability in specific brain regions may serve as a reliable biomarker for SE-induced epileptogenesis and together with our findings showing losartan as anti-epileptogenic drug, highlight the potential of specific anti-epileptogenic treatment for patients identified with high risk to develop epilepsy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalNeurological Disorders
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Guy Bar Klein”
  • BylineArticles whose byline prints “Netta Elazary”
  • BylineArticles whose byline prints “Nadav Milk”
  • BylineArticles whose byline prints “Yossi Rosman”
  • BylineArticles whose byline prints “Svetlana Lublinsky”
  • BylineArticles whose byline prints “Evyatar Swissa”
  • BylineArticles whose byline prints “Arik Eizenkraft”
  • BylineArticles whose byline prints “Lyn Kamintsky”